Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
Section snippets
Acknowledgements
This study was supported by grants from the Swedish Research Council (projects 2006–6227 [HZ] and 2006–2740 [KB]), the Alzheimer's Association (project NIRG-08-90356 [HZ]), the Sahlgrenska University Hospital, the Göteborg Medical Society, Stiftelsen för Gamla Tjänarinnor, the Alzheimer Foundation, Sweden, the Åke Wiberg Foundation, Gun och Bertil Stohnes Stiftelse and Tore Nilsons Stiftelse för Medicinsk Forskning.
References (39)
- et al.
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
Neuron
(2000) - et al.
Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
Neurosci. Lett.
(2000) - et al.
Mini-mental state. A practical method for grading the cognitive state of patients for the clinician
J. Psychiatr. Res.
(1975) - et al.
Multiple-system atrophy: a new alpha-synuclein disease?
Lancet
(1998) - et al.
Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
Neuron
(1995) - et al.
Identification of two distinct synucleins from human brain
FEBS Lett.
(1994) - et al.
Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Biochem. Biophys. Res. Commun.
(2006) - et al.
The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain
Brain Res.
(2004) - et al.
A more efficient enzyme-linked immunosorbent assay for measurement of alpha-synuclein in cerebrospinal fluid
J. Neurosci. Methods
(2008) - et al.
Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly
Neurosci. Lett.
(2004)
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization
Neurosci. Lett.
(2000)
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease
Arch. Neurol.
(1999)
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
Am. J. Pathol.
(1998)
Red blood cells are the major source of alpha-synuclein in blood
Neurodegener. Dis.
(2008)
Rat Hybridomas and Rat Monoclonal Antibodies
(1990)
Parkinson's disease: a genetic perspective
FEBS J.
(2008)
Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele
J. Neural. Transm.
(1996)
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?
Mol. Chem. Neuropathol.
(1995)
Cited by (189)
Cerebrospinal fluid protein biomarkers in Parkinson's disease
2024, Clinica Chimica ActaDetection and assessment of alpha-synuclein in Parkinson disease
2022, Neurochemistry InternationalBiomarkers and diagnosis of dementia with Lewy bodies including prodromal: Practical aspects
2022, Revue NeurologiqueCSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment
2020, Trends in Pharmacological SciencesMolecular profiling in Parkinsonian syndromes: CSF biomarkers
2020, Clinica Chimica ActaGBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies
2020, Molecular Genetics and Metabolism
Copyright © 2008 Elsevier Ireland Ltd. All rights reserved.